A look at how patient engagement is finally a focus for drug delivery

ByElly Earls

30 Jul 21

We find out why sponsors and regulators are finally working to increase patient engagement across the life cycle…

Clinical trials

Diversity in clinical trials: How FDA guidance can improve inclusivity

ByMonica Karpinski

23 Jul 21

We look at how, according to industry experts, professionals can look to guidance from the FDA to improve…

Clinical trials

J&J’s single-shot Covid-19 vaccine shows promise against Delta variant

By NS Healthcare Staff Writer

05 Jul 21

The data included new analysis from blood samples obtained from a subset of participants in the Phase 3…

PharmaceuticalsClinical trials

Starpharma’s Viraleze nasal spray effective against multiple Covid-19 variants

By NS Healthcare Staff Writer

21 Jun 21

Starpharma claims that its Viraleze is the only nasal spray to show more than 99.9% antiviral activity against…

PharmaceuticalsClinical trials

Sage, Biogen’s MDD drug Zuranolone meets primary endpoint in Phase 3 trial

By NS Healthcare Staff Writer

16 Jun 21

Sage and Biogen claimed that their investigational drug Zuranolone is a potential breakthrough in the management of depression

PharmaceuticalsClinical trials

AstraZeneca Covid-19 vaccine shows 92% efficacy against Delta variant

By NS Healthcare Staff Writer

16 Jun 21

According to the new data, the AstraZeneca Covid-19 vaccine is 92% effective against the Delta variant, and 86%…

PharmaceuticalsClinical trials

Novavax’s Covid-19 vaccine shows 90% efficacy in Phase 3 trial

By NS Healthcare Staff Writer

15 Jun 21

The Phase 3 PREVENT-19 study also met the key secondary endpoint of 100% efficacy against variants not considered…

PharmaceuticalsClinical trials

Novavax unveils positive data for Covid-19 vaccine against B.1.351 variant

By NS Healthcare Staff Writer

14 Jun 21

Novavax vaccine against Beta (B.1.351) variant virus showed a high immunogenic response in mice and produced neutralising antibodies

PharmaceuticalsClinical trials

Sanofi, GSK start phase 3 clinical trial of Covid-19 vaccine candidate

By NS Healthcare Staff Writer

28 May 21

Through a two-stage design, the phase 3 trial will evaluate vaccine formulations targeting original D.614 virus along with…

PharmaceuticalsClinical trials

Pfizer starts co-administration study with its 20vPnC and Covid-19 Vaccine

By NS Healthcare Staff Writer

25 May 21

The coadministration trial is primarily aimed at determining the safety when both vaccines are co-administered, with follow up…

PharmaceuticalsClinical trials